Shire PLC (LON:SHP)‘s stock had its “buy” rating restated by equities researchers at HSBC in a report issued on Tuesday. They presently have a GBX 5,400 ($71.92) target price on the biopharmaceutical company’s stock. HSBC’s target price would suggest a potential upside of 5.99% from the company’s previous close. A number of other equities research […]
